The data on the inhibition of the angiotensin-converting enzyme (ACE) activity, acetylcholinesterase (AChE) activity, and advanced glycation endproduct (AGE) formation are important regarding hypertension, Alzheimer-type dementia, and diabetic complication, respectively. This evidence concerns the gene ACE and hypertensive disorder.